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At low doses, A^-nitrosomethylethylamine (NMEA) selectively
produces liver tumors in rats, whereas /3-trideuterated NMEA
also includes esophageal carcinomas under these conditions.
Since deuteration is capable of retarding enzymic hydroxyl-
ation, these studies suggest that /3-hydroxylation plays a sig-
nificant role in the organ specificity of NMEA. To test the
hypothesis that this metabolic pathway occurs in vivo to yield
a hydroxyethylating intermediate, we have determined the
extent of hydroxyethylation of hepatic DNA in male Fischer
344 rats following a single i.p. injection of [l-ethyM*C]NMEA
(6.3 mg/kg, 4 h survival). After hydrolysis in 0.1 M HC1,
DNA purines were analysed by cation exchange chromatogra-
phy. Of the major alkylpurines identified, 7-ethylguanine
(7-etG) (6.7 ^mol/mol guanine) and O6-ethylguanine
(4.1 /imol/mol guanine) comprised 13 and 8% of the eluted
radioactivity, respectively. 7-(2-HydroxyethyI)guanine (7-heG)
was the only hydroxyethyl adduct detectable, and comprised
less than 2% of the amount of 7-etG. 3-Ethylguanine and
3- and 7-ethyladenine were also identified as products of
NMEA metabolism. Similar analyses were carried out on
hepatic DNA from rats treated with N-
nitrosodi[l-14C]ethylamine (6.9 mg/kg, 4 h survival). Only
trace amounts of 7-heG could be detected. The very low
concentrations of /3-hydroxyethylated DNA bases observed
suggest that this route of metabolism does not contribute
significantly to the carcinogenicity of these compounds.
to determine to what extent /?-hydroxylation of NMEA (Figure
1) yields a hydroxyethylating intermediate. White et al. (10) have
recently shown that porphyrins in the livers of mice receiving
A^-nitrosodi[l-14C]ethylnitrosamine ([l-ethyl-14C]NDEA) were
hydroxyethylated rather than ethylated. We have, therefore, also
studied DNA hydroxyethylation by [l-ediyl-14C]NDEA. The pat-
tern of alkylated DNA bases was analysed on a cation exchange
chromatography system in which 7-(2-hydroxyethyl)guanine
(7-heG) was clearly separated from other DNA purines. The
results provide evidence that NMEA and A'-nitrosodiethylamine
(NDEA) are /3-hydroxylated in vivo and subsequently hydroxy-
ethylate DNA, although to a very small extent.
Materials and methods
Chemicals
NMEA l<C-labeled in the 1-ethyl position was prepared as previously described
(9). [1-Ethyl-'*C]NDEA was obtained from New England Nuclear (Boston, MA).
Both nitrosarrunes were dissolved in physiological saline at specific activities of
17 mCi/mmol for [l-ethyl-14C]NDEA and 14 or 32 mCi/mml for [l-ethyl-14C]-
NMEA. The concentrations of solutions administered were 2.8 mM for
[l-ethyl-"C]NDEA and 12 mM for [l-ethyl-14C]NMEA at 14 mCiAnmol and
1.6 mM at 32 mCi/mmol. The standards 7-heG and O*-(2-hydroxyethyl)guanine
(O*-heG) were a gift from Dr D.Ludlum, 7-ethylguanine (7-etG) was from Dr
W.Lijinsky, and O*-ethylguarune (O*-etG) was purchased from EMKA-Chemie
(Markgroningen, FRG).
Animals and treatments
Male Fischer 344 rats weighing 100-150 g were obtained from Charles River
Wiga (FRG) and given food and water ad libitum. The two nitrosamines were
administered i.p. in physiological saline. In the first experiment, [l-ethyl-14C]-
NMEA was administered to six animals at 0.05 mmol/kg (sp. act. 14 mCi/mmol).
In a second experiment, the same compound was given to one animal at a dose
of 6.3 mg/kg (0.07 mmol/kg, sp. act. 32 mCi/mmol); the survival time was
4 - 5 h. [1-Ethyl-"C]NDEA was given to two animals at a dose of 6.9 mg/kg
(0.07 mmol/kg) with a survival time of 4 h.
Analysis
DNA was isolated by phenol extraction and adsorption onto hydroxylapatite as
Introduction
The study of enzymic hydroxylation of aliphatic N-nitroso com-
pounds at other than the a-carbon atom has previously focused
on long-chain dialkylnitrosamines (1,2,3). There is evidence that
/V-nitroso compounds containing an ethyl group are also co-
hydroxylated (4). The involvement of /S-hydroxylation as a modi-
fying factor in the carcinogenicity of N-nitrosomethylethylamine
(NMEA*) has been suggested by the altered tissue specificity
of NMEA deuterated on the /5-carbon of the ethyl group (5,6).
This deuterated analog produces significantly more esophageal
tumors than does the parent compound, probably due to impaired
/3-hydroxylation (7,8). We have previously shown that NMEA
is hydroxylated at both the methyl group and at the or-position
of the ethyl group to yield an ethylating and a methylating species
in vivo, respectively (9). The purpose of the present study was
•Abbreviations: NMEA, /V-rutrosomethylethylamine; NDEA, /V-nitrosodicthyl-
amine: 7-etG, 7-ethylguanine; 7-heG, 7-(2-hydroxyethyl)guanine; O*-etG,
O*-ethylguanine; C-heG, O*-(2-hydroxyethyl)guanine; 3-etG, 3-ethylguanine;
3-etA, 3-ethyladenine; 7-etA, 7-ethyladenine; G, guanine; A, adenine.
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Fig. 1. Proposed pathways /or the metabolism of /V-nitrosomethylethylamine
in vivo, including 0-hydroxylation.
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previously described (9). It was then depurinated for 20 h at 37°C in 0.1 MHO.
When authentic 7-heG and O*-heG were submitted to this treatment, no degradation
of the standards could be observed by u.v. detection following h.p.l.c. on a 0.45 x
25 cm Partisil SCX column eluted with 50 mM NHiH2PO4 and 10% (v/v) meth-
anol (pH 2.0). In the first experiment, the DNA purines from 16 g of pooled
livers from animals treated with 0.05 mmol/kg [l-ethyl-14C]NMEA was loaded
onto a Sephasorb-HP column (1 x 40 cm) and eluted with water at a flow rate
of 1.5 ml/min (fraction volume, 3.5 ml). Under these conditions, 7-heG was
previously found to elute at fraction 14. Fractions 12-16 were pooled, evapor-
ated under a stream of purified air to 200 /d and analysed by h.p.l.c. as described
above, after the addition of cold 7-heG marker. Fractions were collected every
0.3 min and counted for radioactivity after the addition of 5 ml Riatron scintil-
lation cocktail. The chromatographic system used to separate radiolabeled purine
adducts in the second experiment using [l-ethyl-14C]NMEA at a higher specific
activity and using [l-ethyl-"C]NDEA was that described by Lawley el ai. (11).
Authentic 7- and O*-heG as well as 7-etG and C-etG were added to the hydro-
lysates as optical markers. The resulting mixture was brought to 0.3 M ammonium
formate (pH 8.9) by the addition of 3 M ammonium formate and 1 M sodium
hydroxide and loaded onto a 70 X 1 cm column of Bio-Rad AG 50W-X4 minus
400 mesh resin (ammonium form). DNA bases were eluted with 0.3 M ammonium
formate (pH 8.9) at a flow rate of 7 ml/h. This cation exchange system has the
advantage that 7-heG, the major hydroxyethylated adduct expected, elutes far
from the solvent front and away from other bases. Peaks were identified by their
retention times relative to adenine and added optical markers. Radioactivity was
quantified in 3.5 ml fractions following the addition of 6 ml Riatron.
Results
In the first experiment using [l-ethyl-^JNMEA at 14 mCi/
mmol, a small peak of radioactivity was observed to co-chromato-
graph with 7-heG after analysis by h.p.l.c. (data not shown).
Since the sample was analysed by two separate chromatographic
systems with a concentration step in between, it was not poss-
ible to reliably correct for recovery and thus the amount of adduct
could not be quantified in terms of /imol 7-heG/mol guanine.
The amounts of ethylated and hydroxyethylated DNA purines
produced by NMEA and NDEA detected following separation
on AG 5O-X4 resin are shown in Table I. In all analyses, 3-ethyl-
guanine (3-etG), 3-ethyladenine (3-etA), 7-etG, 7-ethyladenine
(7-etA) and O6-etG were identified. In addition, DNA from ani-
mals treated with [l-ethyl-14C]NMEA showed a small radio-
labeled peak which co-chromatographed with 7-heG (Figure 2).
This peak contained 1.3% of the radioactivity found in the 7-etG
peak. In the DNA of animals treated with [l-ethyl-X4C]NDEA,
a radioactive peak with the retention time of 7-heG also was pres-
ent, but its height was less than twice the background activity
(Figure 3). From the specific activity of [l-ethyl-a*C]NDEA
administered it was calculated that the amount of 7-heG present
was below 0.4 fimol/mol guanine, i.e. less than 1 % of the 7-etG
in the same chromatogram. O6-heG was not detectable, but this
may have been due to partial co-elution with 7-etA. The relative
amounts of the remaining adducts produced by [l-ethyl-14C]-
NMEA were comparable with those produced by [l-ethyl-14C]-
NDEA, with the one notable exception that the O6-etG
to 7-etG ratio was higher for [l-ethyl-14C]NMEA than for
[l-ethyl-14C]NDEA.
Fig. 2. Ion exchange chromatographic profile of hepatic DNA punnes from
a male Fischer 344 rat injected i.p. with 6.3 mg/kg [l-ethyl-"C]NMEA
(32 mCi/mmol): - A - A - , u.v. (254 nm) absorbance; — • — • — ,
radioactivity (d.p.m.).
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Fig. 3. Chromatographic profile of hepatic DNA purines from male Fischer
344 rats injected i.p. with 6.9 mg/kg [l-ethyl-l4C]NDEA (17 mCi/mmol):
— • — H — , radioactivity (d.p.m.).
Table I. DNA
Adduct
Front
7-heG
3-etG
3-€tA
7-etG
7-etA
C-etG
O«-eiG/7-etG
7-heG/7-etG
adducts produced by ethylating
Retention time
relative to
adenine (=100)
15
69
85
99
129
139
204
nitroso compounds in vim
[1-Ethyl-'*C]NMEA"(6 3
Percentage of total
d.p.m. eluted
73
0.17
1.3
3.2
13
0.75
8.0
0.61
0.013
mg/kg)
funoVmol
G or A
0.09
0.66
1.2
6.7
0.27
4.1
[l-Ethyl-'«C]NDEAb (6.9
Percentage of total
d.p.m. eluted
66
<0.2
2.0
3.5
19
0.97
6.9
0.36
<0.01
mg/kg)
(imol/mol
G or A
<0.4
3.6
4.6
34
1.3
13
•Single analysis of DNA from the liver of one rat.
bMean of two determinations of DNA from pooled livers of two rats.
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Discussion
The present investigation has shown that ^-hydroxylation of
NMEA occurs in vivo, yielding a hydroxyethylating intermediate.
Following administration of 0.07 mmol/kg of [l-ethyl-14C]-
NMEA, a radioactive peak co-eluting with 7-heG was clearly
identifiable and amounted to 1.3% of the 7-etG present. In the
case of [l-ethyl-14C]NDEA, the extent of/3-hydroxyethylation
at the 7-position of guanine was less than 1 % of the extent of
ethylation. From in vitro studies on alkylation by N-nitroso-
hydroxyethylurea one would expect an O6/7-heG ratio close to
0.72 (12). In the present study we could not detect OMieG, prob-
ably due to the low extent of its formation and partial co-elution
with 7-etA (Figure 2). In addition, the possibility exists that this
promutagenic base was partially repaired during the course of
the experiment. C^-heG is a substrate for C^-alkylguanine-DNA
alkyltransferase, although the rate of repair is considerably slower
than for O6-methylguanine or C-etG (12, 13). The relative
amounts of ethylated bases observed (Table I) correspond closely
to those determined in DNA treated with N-nitrosoethylurea in
vitro (14). It is noteworthy that the O6-/7-etG ratio is markedly
lower in the DNA from animals receiving [l-ethyl-14C]NDEA
than from animals receiving [l-ethyl-14C]NMEA (Table I); most
likely this reflects partial saturation of O6-alkylguanine-DNA
alkyltransferase by O6-methylguanine, levels of which exceed
those of C^-etG by approximately 30-fold following adminis-
tration of [l-ethyl-14C]NMEA (9).
From the work of White et al. (10) we expected that /3-hy-
droxylation of ethylating nitrosamines might constitute a major
metabolic pathway. Following the administration of [l-ethyl-14C]-
NDEA (1 mmol/kg) they found in mouse liver hydroxyethyl-
protoporphyrin IX rather than an ethylprotoporphyrin. They
suggested that this was due to /S-hydroxylation of NDEA followed
by a-C hydroxylation to yield a hydroxyethyldiazonium ion as
the ultimate reactant, analogous to the bioactivation of NMEA
shown in Figure 1. When taking DNA modification rather than
reaction with proteins as a biological endpoint of NDEA metab-
olism in rats, it would seem that /3-hydroxylation is either a minor
pathway or that subsequent activation of /3-hydroxylated NMEA
or NDEA leading to DNA hydroxyethylation is not a favoured
reaction. In the latter case, /3-hydroxylation of NMEA could serve
as an effective detoxification pathway. We have not, however,
ruled out the possibility that /3-hydroxylated NMEA may undergo
subsequent a-hydroxylation of the hydroxyethyl moiety to yield
a methylating agent (Figure 1). The contrasting type of alkyl-
ation of prophyrins and deoxyribonucleotides may reflect an intra-
cellular heterogeneity of nitrosamine metabolism and/or
differences in the respective nucleophiles participating in the
alkylation reaction as well as species differences.
Our observations are in agreement with numerous studies on
DNA alkylation by NDEA (15,16), NMEA (9) and JV-nitroso-
ethylurea (17). All these in vivo studies clearly demonstrate that
DNA ethylation is the major type of adduct formed by transfer
of the 2-carbon N-substituent to DNA. In addition, other workers
have very recently obtained evidence for DNA 2-hydroxyethyl-
ation in independent investigations with NDEA (H.G.Floss and
Y.-H.Heur, personal communication).
Carcinogenicity studies with yV-nitrosohydroxyethylurea indi-
cate that DNA hydroxyethylation in vivo is an initiating event
at least as potent as DNA ethylation (18). However, the very
low extent of DNA hydroxyethylation observed in the present
study suggests that enzymic /3-hydroxylation of ethylating nitroso
compounds does not contribute significantly to their carcinogen-
icity. The shift in organ specificity by /3-trideuteration of NMEA
from liver to esophagus is, therefore, unlikely to result from dif-
ferent levels of DNA hydroxyethylation. The possibility exists
that /3-trideuteration of NMEA retards its overall metabolism in
rat liver, allowing increased exposure of extra-hepatic tissues.
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